San Francisco & Shanghai–April 16, 2026

Against the backdrop of deepening integration and accelerating cross-border collaboration in global biopharmaceutical innovation, TONACEA, a leading industrial ecosystem platform dedicated to China’s biopharmaceutical innovation sector, has signed a cooperation agreement with BioCentury, the global leader in biopharmaceutical business intelligence and C-level conferences. Centered on a China‑U.S. dual engine, the two parties will jointly build a new ecosystem for global biopharmaceutical innovation and collaboration.

The parties agree to leverage their respective platform resources and industry expertise to support each other’s flagship industry summits, including brand promotion, guest invitations, and conference marketing. Specifically, TONACEA has invited BioCentury to serve as a think‑tank platform supporting the inaugural China Pharmaceutical Innovation Conference (CPIC). TONACEA will also support the 13
th BioCentury-BayHelix China Healthcare Summit. 

In this collaboration, both parties will draw on their respective platform strengths and industry resources to support one another’s flagship summits through comprehensive cooperation including joint brand communications, guest outreach, and global conference promotion. TONACEA has specially invited BioCentury to provide in‑depth support as a think‑tank platform for the inaugural “Great Power New Drugs” Global Conference (CPIC). Leveraging BioCentury’s global industry influence and resource network, the two sides will expand CPIC’s international visibility and industry impact through official website linkage, cross‑media promotion, and channel sharing, building a key bridge for China’s biopharmaceutical innovation to reach the world and connect with global resources.

Dr. Zengjiang Cheng, Founder and Chairman of TONACEA, stated:“This strategic partnership with BioCentury represents a major milestone in fulfilling TONACEA’s mission of ‘connecting the global ecosystem and empowering growth in biopharmaceutical innovation.’Together, we will deploy top‑tier resources and professional capabilities to build a core hub for China‑U.S. biopharmaceutical cooperation, continuously unlock cross‑border synergies, and help China’s innovative drugs go global.”

Mr. Joshua Berlin, Head of Corporate Alliances and Business Development for BioCentury, commented:“We are honored to partner with TONACEA, a central platform in China’s biopharmaceutical innovation ecosystem.Drawing on BioCentury’s 30-plus years of building cross-border networks, we will work together to  help connect Western and China biopharma leaders to accelerate drug development and biopharma innovation.”

Scan the QR code to register now!
Limited-time early bird tickets at 40% off – grab yours now!!
The overseas registration link will be available soon. Stay tuned!

About TONACEA

TONACEA is China’s premier ecosystem platform dedicated to biopharmaceutical innovation. With over two decades of deep-seated engagement in the biopharma innovation landscape, it has evolved into a pivotal powerhouse driving the nation’s pharmaceutical progress and a strategic nexus connecting multinational corporations (MNCs) with local innovators.

The platform converges a high-caliber network—comprising MNCs, biotechs, investment firms, research institutes, and regulatory bodies—to foster an integrated knowledge-sharing architecture across the entire R&D value chain.

TONACEA’s comprehensive service portfolio encompasses flagship industry summits, technical forums, bespoke corporate training, media dissemination, and strategic consultancy. With a robust operational footprint spanning Suzhou, Shanghai, Beijing, and Guangzhou, the platform projects strategic influence nationwide.

Through its influential media channels, TONACEA consistently delivers deep-dive industry intelligence, earning its reputation as a "trusted official source" frequently cited by the investment community and mainstream media. Furthermore, the co-initiated "Huashan Awards" have set the gold standard for the internationalization of Chinese innovation, empowering homegrown enterprises to command the global stage.

About BioCentury

Headquartered in San Mateo, California, BioCentury is the world’s preeminent biopharmaceutical intelligence platform. For more than 30 years, it has been recognized as the gold standard by biopharma pharama executives, investors, and policymakers, with a mission to empower the next generation of biotech leaders.

As the organizer of several premier international events including the BioCentury‑BayHelix China Healthcare Summit, BioCentury stands as an authoritative hub for cross‑border biopharmaceutical collaboration and innovation ecosystems.